每经头条（nbdtoutiao）——2025十大财经新闻出炉！护航、酣战、变局、狂飙分别指向哪些大事件？ 每经AI快讯，东杰智能12月30日晚间发布公告称，公司于2025年12月17日披露了《东杰智能科技集团 股份有限公司关于筹划发行股份及支付现金购买资产并募集配套资金暨关联交易事项的停牌公告》（公 告编号：2025-160），公司拟以发行股份及支付现金的方式购买山东齐康智合创业投资管理有限公司等 交易对方合计持有的遨博（北京）智能科技股份有限公司（以下简称"遨博智能"或"标的公司"）控股权 并配套募集资金。经审慎研究，公司决定终止筹划本次重大资产重组事项。 本次交易尚处于筹划阶段，交易相关方均未就具体方案签署正式协议，相关议案尚未提交公司董事会及 股东会审议，重组事项尚未正式实施，交易双方对终止本次重大资产重组无需承担任何违约责任。本次 终止筹划重大资产重组事项不会对公司业务开展、生产经营活动和财务状况造成不利影响，亦不存在损 害公司及股东特别是中小股东利益的情形。 公司股票将于2025年12月31日（星期三）开市起复牌。 （记者 王晓波） ...

东杰智能科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 17 日披露了《东杰智能科技集团股份有限公司关于筹划发行股份及支付现金购买资 产并募集配套资金暨关联交易事项的停牌公告》（公告编号：2025-160），公司 拟以发行股份及支付现金的方式购买山东齐康智合创业投资管理有限公司等交 易对方合计持有的遨博（北京）智能科技股份有限公司（以下简称"遨博智能" 或"标的公司"）控股权并配套募集资金（以下简称"本次交易"或"本次重大 资产重组"）。经审慎研究，公司决定终止筹划本次重大资产重组事项。现将有 关情况公告如下： 证券代码：300486 证券简称：东杰智能 公告编号：2025-162 东杰智能科技集团股份有限公司 关于终止筹划重大资产重组事项并复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 筹划本次重大资产重组以来，公司及相关各方严格按照相关法律法规的要求， 积极推动本次重大资产重组相关的各项工作，与本次重大资产重组的交易对方进 行了积极磋商和沟通。经充分研究相关方意见，积极磋商和认真探讨后，认为公 司目前实施重大资产重组的条件尚 ...

东杰智能公告，公司决定终止筹划发行股份及支付现金购买遨博（北京）智能科技股份有限公司控股权 并配套募集资金的重大资产重组事项。公司股票将于2025年12月31日开市起复牌，并承诺自公告披露之 日起1个月内不再筹划重大资产重组。本次交易尚处于筹划阶段，相关议案尚未提交公司董事会及股东 会审议，重组事项尚未正式实施，交易双方对终止本次重大资产重组无需承担任何违约责任。本次终止 筹划重大资产重组事项不会对公司业务开展、生产经营活动和财务状况造成不利影响。 ...

出品：新浪上市公司研究院 7月30日晚，东杰智能发布公告，公司于2025年7月30日收到控股股东淄博匠图恒松控股有限公司（简 称"淄博匠图"）的告知函，淄博匠图控股股东淄博展恒鸿松股权投资基金合伙企业（有限合伙）的有限 合伙人淄博市财金控股集团有限公司拟将其持有的淄博展恒99%的基金份额进行转让，该事项可能导致 公司实际控制人发生变动。 8月26日，东杰智能再次公告，淄博财金与海南鹤平签署了《基金份额转让协议》，淄博财金拟将其持 有的淄博展恒99%的基金份额转让给海南鹤平，交易价格为16.2亿人民币，海南鹤平同意受让。本次交 易完成后，淄博匠图持有的公司股份数量不变，公司控股股东仍为淄博匠图。公司实际控制人由淄博市 财政局变更为自然人韩永光。同时，韩永光当选为东杰智能董事长。 至此，我们疑惑的是，为何韩永光采取先控股后注入，且不控股标的资产。 规避借壳上市？先控股后注入 此次借壳标的属于公司实控人韩永光持股标的。公司实际控制人、董事长韩永光先生仅间接持有遨博智 能7.1681%的股份。此次交易构成关联交易。 需要指出的是，此次实控人韩永光资本运作采取了先控股后资产注入的策略。 文/夏虫工作室 核心观点：遨博智 ...

证券日报网讯12月23日，东杰智能（300486）在互动平台回答投资者提问时表示，截至2025年12月19日 持有公司股份人数(已合并)为30028户。 ...

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

交易事项的停牌进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 东杰智能科技集团股份有限公司（以下简称"公司"）正在筹划发行股份及 支付现金购买山东齐康智合创业投资管理有限公司等交易对方合计持有的遨博 （北京）智能科技股份有限公司控股权（以下简称"本次交易"）并配套募集资 金。 因有关事项尚存在不确定性，为维护投资者利益，避免对公司证券交易造成 重大影响，根据深圳证券交易所的相关规定，经公司申请，公司股票（证券品种： A 股股票，证券简称：东杰智能，证券代码：300486.SZ）自 2025 年 12 月 17 日 开市时起开始停牌。 公司预计在不超过 10 个交易日的时间内披露本次交易方案，即在 2025 年 12 月 30 日前按照《公开发行证券的公司信息披露内容与格式准则第 26 号—— 上市公司重大资产重组》的要求披露相关信息，并申请复牌。具体内容详见公司 刊 登 于 中 国 证 监 会 指 定 的 创 业 板 信 息 披 露 网 站 巨 潮 资 讯 网 （http://www.cninfo.com.cn）的《东杰智能科技集团股份有限公司关于筹 ...

New Stock Listings - One new stock listed today: Muxi Co., Ltd. (688802) with an issue price of 104.66 yuan [1] Industry News - The Ministry of Commerce announced the imposition of anti-dumping duties on imported pork and pork products from the EU for a period of five years starting today [1] - The 2025 Xiaomi Human-Vehicle Home Ecosystem Partner Conference is being held today [1] - The 2025 China Artificial Intelligence Industry Innovation and Development Conference is taking place today [1] - The Second Global Data Technology Conference (GDTC) is being held in Beijing from today until the 18th [1] - The Fourth Computing Power Network and Digital Economy Forum, along with the 2025 "Computing Power Puxiang" Conference, is being held today [1] - Dell announced a price increase for all its commercial product lines starting today, attributed to demand for memory chips [1] - The U.S. Trade Representative's office warned of potential retaliatory measures against the EU's service industry and may initiate a Section 301 investigation [1] - The U.S. FDA approved a twice-a-year asthma medication from GlaxoSmithKline [1] - Autonomous driving company Waymo is reportedly discussing raising several billion dollars at a valuation exceeding $100 billion [1] - Tesla's stock price reached a historic high, with a market capitalization exceeding $1.6 trillion, reflecting growing optimism about autonomous driving [1] - Level 3 autonomous driving has been approved, with Changan Automobile and BAIC Blue Valley models receiving pilot approval [1] - Apple plans to expand its iPhone product line from five to seven models before fall 2027 [1] - OpenAI appointed former UK Chancellor Osborne to lead the "OpenAI for Countries" initiative [1] - AI data platform Databricks is reportedly raising over $4 billion at a valuation of $134 billion [1] - The European Commission plans to issue approximately €90 billion in bonds in the first half of next year [1] Economic Data - A total of 189.8 billion yuan in 7-day reverse repos is maturing today [1] - Various economic indicators are being released, including Japan's trade balance, export and import amounts for November, and the UK's core CPI [1] - Germany's Ifo Business Climate Index for December and HICP data for November are being published [1] - Italy's HICP data for November is also being released [1] - Eurozone's November CPI and core CPI data are being reported [1] - U.S. retail inventory adjustments and EIA crude oil inventory changes for the week ending December 12 are being released [1] A-Share Market Dynamics - Six listed companies are facing stock unlocks, including Oke Technology with 70 million shares (74.99% of total shares) and Meino Biological with 13.88 million shares (9.86%) [1] - Several companies announced dividend distributions, with Chongqing Brewery (10 shares for 13 yuan) and Wuliangye (10 shares for 25.78 yuan) among those with significant payouts [1] - Dongjie Intelligent is planning to acquire a controlling stake in Aobo Intelligent, leading to a stock suspension [1] - Multiple companies released important announcements, including 360 clarifying rumors of financial fraud and Longping High-Tech planning a 1 billion yuan investment in production bases in Vietnam and Malaysia [1] - Lianhua Holdings' subsidiary plans to purchase acceleration cards for intelligent computing business for 200 million yuan [1] - Hualing Cable intends to acquire 70% of San Zhu Technology for 183 million yuan [1] - Xiechuang Data signed a strategic cooperation framework agreement to enter the optical chip and module industry [1]

12月17日，东杰智能科技集团股份有限公司（下称"东杰智能"）停牌。 值得注意的是，今年8月底，东杰智能发布公告披露，8月25日，淄博市财金控股集团有限公司（下 称 "淄博财金"）与海南鹤平投资有限公司（下称 "海南鹤平"）已正式签署《基金份额转让协议》。根 据协议，淄博财金拟将其持有的淄博展恒99%的基金份额转让给海南鹤平，本次交易对价为16.2亿元。 上述公告明确，若此次基金份额转让顺利推进并完成，公司控股股东仍为淄博匠图，其持股数量保 持不变，但公司实际控制人将正式变更为韩永光。与此同时，东杰智能同步披露，韩永光已被选举为公 司董事长。 值得关注的是，韩永光与本次重大资产重组的标的公司——遨博智能存在关联关系，其目前担任遨 博智能董事。此外，韩永光还同时出任易嘉油智能机器人有限责任公司董事、电科北方电子科技（山 东）有限公司董事长，而上述两家企业均涉足具身机器人领域。因此，在外界看来，这也为东杰智能此 次拟收购遨博智能控股权、切入协作机器人赛道埋下了伏笔。 根据遨博智能官网，其成立于2015年，是一家专注于协作机器人研发、生产和销售的国家高新技术 企业，拥有全行业最完备的协作机器人和移动操作机器人产品矩 ...

因上述重大资产重组尚存在不确定性，东杰智能股票自12月17日开市起停牌。在二级市场，东杰智能是2025年的"牛股"之一，是机器人概念股，一度创 下28.90元的新高。12月16日，东杰智能股价大涨近10%，收报21.59元/股，年初至今，该公司股票涨幅累计达215.64%，最新市值为103亿元。 刚完成实际控制人变更不久，A股上市公司东杰智能（300486）(SZ300486)宣布了一则重大资产重组消息。 12月16日晚，东杰智能称，公司正在筹划发行股份及支付现金购买山东齐康智合创业投资管理有限公司等交易对方合计持有的遨博(北京)智能科技股份 有限公司(以下简称遨博智能)控股权并配套募集资金。本次交易预计构成重大资产重组、构成关联交易，但不构成重组上市。 信息显示，遨博智能是一家从事协作机器人研发、生产和销售的公司。东杰智能实控人、董事长韩永光间接持有遨博智能约7.17%股份。公司已完成D轮 融资，投资方包括复星集团、中电基金等机构。 东杰智能2025年三季报显示，公司前三季度营业收入为6.98亿元，同比增长26.46%；实现净利润835.29万元，同比扭亏为盈。 今年8月26日，东杰智能发布公告称，公司实际 ...